|
Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2018 |
Sep 26 2018 |
96 |
Global |
$2,000.00 |
|
|
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Pipeline Review, H2 2018 |
Sep 26 2018 |
73 |
Global |
$3,500.00 |
|
|
Tetanus - Pipeline Review, H2 2018 |
Sep 26 2018 |
87 |
Global |
$2,000.00 |
|
|
Epstein-Barr Virus (HHV-4) Infections - Pipeline Review, H2 2018 |
Sep 26 2018 |
209 |
Global |
$2,000.00 |
|
|
Methionine Aminopeptidase 2 (Initiation Factor 2 Associated 67 kDa Glycoprotein or Peptidase M 2 or eIF 2 Associated p67 Homolog or METAP2 or EC 3.4.11.18) - Pipeline Review, H2 2018 |
Sep 26 2018 |
59 |
Global |
$3,500.00 |
|
|
Herpes Zoster (Shingles) - Pipeline Review, H2 2018 |
Sep 26 2018 |
55 |
Global |
$2,000.00 |
|
|
Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H2 2018 |
Sep 26 2018 |
55 |
Global |
$2,000.00 |
|
|
Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) - Pipeline Review, H2 2018 |
Sep 26 2018 |
57 |
Global |
$3,500.00 |
|
|
Glaucoma - Pipeline Review, H2 2018 |
Sep 26 2018 |
308 |
Global |
$2,000.00 |
|
|
Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) - Pipeline Review, H2 2018 |
Sep 26 2018 |
96 |
Global |
$3,500.00 |
|
|
Hand, Foot and Mouth Disease - Pipeline Review, H2 2018 |
Sep 26 2018 |
43 |
Global |
$2,000.00 |
|
|
Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Pipeline Review, H2 2018 |
Sep 26 2018 |
28 |
Global |
$3,500.00 |
|
|
Pseudomonas aeruginosa Pneumonia - Pipeline Review, H2 2018 |
Sep 26 2018 |
33 |
Global |
$2,000.00 |
|
|
Tinnitus - Pipeline Review, H2 2018 |
Sep 26 2018 |
46 |
Global |
$2,000.00 |
|
|
Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H2 2018 |
Sep 26 2018 |
220 |
Global |
$2,000.00 |
|
|
Sinusitis - Pipeline Review, H2 2018 |
Sep 26 2018 |
98 |
Global |
$2,000.00 |
|
|
Gamma Secretase (EC 3.4.23.) - Pipeline Review, H2 2018 |
Sep 26 2018 |
51 |
Global |
$3,500.00 |
|
|
Rhinovirus Infections - Pipeline Review, H2 2018 |
Sep 26 2018 |
50 |
Global |
$2,000.00 |
|
|
Neutropenia - Pipeline Review, H2 2018 |
Sep 26 2018 |
118 |
Global |
$2,000.00 |
|
|
Contact Dermatitis - Pipeline Review, H2 2018 |
Sep 26 2018 |
35 |
Global |
$2,000.00 |
|
|
Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Pipeline Review, H2 2018 |
Sep 26 2018 |
61 |
Global |
$3,500.00 |
|
|
Chlamydia Infections - Pipeline Review, H2 2018 |
Sep 26 2018 |
72 |
Global |
$2,000.00 |
|
|
Actinic (Solar) Keratosis - Pipeline Review, H2 2018 |
Sep 26 2018 |
63 |
Global |
$2,000.00 |
|
|
Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 (GABA(A) Receptor Subunit Gamma 2 or GABRG2) - Pipeline Review, H2 2018 |
Sep 26 2018 |
48 |
Global |
$3,500.00 |
|
|
West Nile Virus Infections - Pipeline Review, H2 2018 |
Sep 26 2018 |
73 |
Global |
$2,000.00 |
|
|
Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline Review, H2 2018 |
Sep 26 2018 |
81 |
Global |
$2,000.00 |
|
|
Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H2 2018 |
Sep 26 2018 |
121 |
Global |
$3,500.00 |
|
|
Hepatitis C - Pipeline Review, H2 2018 |
Sep 26 2018 |
399 |
Global |
$2,000.00 |
|
|
Hemophilia B - Pipeline Review, H2 2018 |
Sep 26 2018 |
135 |
Global |
$2,000.00 |
|
|
Cathepsin S (CTSS or EC 3.4.22.27) - Pipeline Review, H2 2018 |
Sep 26 2018 |
32 |
Global |
$3,500.00 |
|
